Highlights a rare case of acute stent thrombosis caused by heparin-induced thrombocytopenia during primary PCI for STEMI.
Consider HIT in acute stent thrombosis during primary PCI; adds rare case evidence but leaves management implications open.
Heparin is an essential drug in the treatment of acute coronary syndrome and it is used during percutaneous coronary intervention (PCI). Heparin-induced thrombocytopenia (HIT), albeit a serious complication of heparin therapy characterized by thrombocytopenia and high risk for venous and arterial thrombosis, has rarely been previously reported during PCI. We report a case of an acute stent thrombosis due to an unusual cause, HIT during primary PCI, in a patient with acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: